Jeffrey Millard
4Patents
2h-index
6Co-inventors
37Inventor score
Filing activity: Feb 23, 2012 → Oct 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8889616B2 | MUC1 based glycolipopeptide vaccine with adjuvant | Human Necessities | 11 | Active |
| US11464749B2 | Bismuth-thiol compositions and methods of use | Emerging Cross-Sectional Technologies | 3 | Active |
| US8329639B2 | MUC1 based glycolipopeptide vaccine with adjuvant | Human Necessities | 0 | Active |
| US12186283B2 | Bismuth-thiol compositions and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.